Depreciation of IN8BIO, INC. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IN8BIO, INC. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • IN8BIO, INC. Depreciation for the quarter ending 30 Sep 2025 was $200,000, a 33% decline year-over-year.
  • IN8BIO, INC. Depreciation for the twelve months ending 30 Sep 2025 was $993,000, a 3.7% increase year-over-year.
  • IN8BIO, INC. annual Depreciation for 2024 was $976,000, a 1.5% increase from 2023.
  • IN8BIO, INC. annual Depreciation for 2023 was $962,000, a 554% increase from 2022.
  • IN8BIO, INC. annual Depreciation for 2022 was $147,000, a 65% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

IN8BIO, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $993,000 $200,000 -$100,000 -33% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,093,000 $300,000 +$100,000 +50% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $993,000 $256,000 +$17,000 +7.1% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $976,000 $237,000 +$18,000 +8.2% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $958,000 $300,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $958,000 $200,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $958,000 $239,000 -$4,000 -1.6% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $962,000 $219,000 +$143,000 +188% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $819,000 $300,000 +$267,000 +809% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $552,000 $200,000 +$178,000 +809% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $374,000 $243,000 +$227,000 +1419% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $147,000 $76,000 +$53,000 +230% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $94,000 $33,000 +$11,000 +50% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $83,000 $22,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $83,000 $16,000 -$6,000 -27% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $89,000 $23,000 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $22,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $22,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $22,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 $22,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $22,000 01 Apr 2020 30 Jun 2020 10-Q 10 Sep 2021 2021 Q2

IN8BIO, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $976,000 +$14,000 +1.5% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $962,000 +$815,000 +554% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $147,000 +$58,000 +65% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $89,000 +$1,000 +1.1% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $88,000 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.